Supernus Pharmaceuticals Inc (SUPN)
28.88
-0.12
(-0.41%)
USD |
NASDAQ |
Apr 18, 16:00
28.88
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Accounts Payable (Quarterly): 1.964M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.964M |
September 30, 2023 | 3.389M |
June 30, 2023 | 4.40M |
March 31, 2023 | 11.54M |
December 31, 2022 | 10.54M |
September 30, 2022 | 16.02M |
June 30, 2022 | 35.52M |
March 31, 2022 | 12.32M |
December 31, 2021 | 9.331M |
September 30, 2021 | 9.125M |
June 30, 2021 | 7.229M |
March 31, 2021 | 5.954M |
December 31, 2020 | 6.147M |
September 30, 2020 | 11.19M |
June 30, 2020 | 5.515M |
March 31, 2020 | 3.124M |
December 31, 2019 | 10.14M |
September 30, 2019 | 3.09M |
June 30, 2019 | 4.081M |
March 31, 2019 | 7.24M |
December 31, 2018 | 3.195M |
September 30, 2018 | 9.838M |
June 30, 2018 | 2.943M |
March 31, 2018 | 3.333M |
December 31, 2017 | 6.844M |
Date | Value |
---|---|
September 30, 2017 | 6.262M |
June 30, 2017 | 7.577M |
March 31, 2017 | 5.056M |
December 31, 2016 | 8.055M |
September 30, 2016 | 2.685M |
June 30, 2016 | 2.243M |
March 31, 2016 | 2.646M |
December 31, 2015 | 4.314M |
September 30, 2015 | 2.812M |
June 30, 2015 | 4.518M |
March 31, 2015 | 0.859M |
December 31, 2014 | 1.863M |
September 30, 2014 | 21.98M |
June 30, 2014 | 19.04M |
March 31, 2014 | 14.66M |
December 31, 2013 | 3.142M |
September 30, 2013 | 14.47M |
June 30, 2013 | 11.73M |
March 31, 2013 | 10.90M |
December 31, 2012 | 10.67M |
September 30, 2012 | 10.48M |
June 30, 2012 | 9.175M |
March 31, 2012 | 9.337M |
December 31, 2011 | 11.76M |
September 30, 2011 | 9.149M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.964M
Minimum
Dec 2023
35.52M
Maximum
Jun 2022
8.980M
Average
7.229M
Median
Jun 2021
Accounts Payable (Quarterly) Benchmarks
Dynavax Technologies Corp | 5.245M |
Ligand Pharmaceuticals Inc | 2.427M |
Pacira BioSciences Inc | 15.70M |
Esperion Therapeutics Inc | 31.72M |
Collegium Pharmaceutical Inc | 8.692M |